Leiomyosarcoma
MONDO:0005058An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.
Also known as: Leiomyosarcomas, leiomyosarcoma, leiomyosarcoma (excluding uterine leiomyosarcoma), leiomyosarcoma - not uterine, leiomyosarcoma, malignant
2874 clinical trials for this condition and its sub-types, 62 tagged with Leiomyosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Leiomyosarcoma
-
Leiomyosarcoma of the corpus uteri 9 trials
2 sub-types
-
Ovary leiomyosarcoma 2 trials
-
Retroperitoneal leiomyosarcoma 2 trials
-
Inflammatory leiomyosarcoma 1 trial
-
Small intestine leiomyosarcoma 1 trial
-
Bone leiomyosarcoma 0 trials
-
Breast leiomyosarcoma 0 trials
-
1 sub-type
- Granular cell leiomyosarcoma 0 trials
-
Colon leiomyosarcoma 0 trials
-
Conventional leiomyosarcoma 0 trials
-
Cutaneous leiomyosarcoma 0 trials
-
Epithelioid leiomyosarcoma 0 trials
1 sub-type
-
Esophagus leiomyosarcoma 0 trials
-
Fallopian tube leiomyosarcoma 0 trials
-
Gallbladder leiomyosarcoma 0 trials
-
Gastric leiomyosarcoma 0 trials
-
Heart leiomyosarcoma 0 trials
-
Kidney leiomyosarcoma 0 trials
-
Laryngeal leiomyosarcoma 0 trials
-
Leiomyosarcoma of the cervix uteri 0 trials
-
Liver leiomyosarcoma 0 trials
1 sub-type
-
Lung leiomyosarcoma 0 trials
-
Mediastinum leiomyosarcoma 0 trials
-
Myxoid leiomyosarcoma 0 trials
1 sub-type
- Uterine corpus myxoid leiomyosarcoma 0 trials
-
Prostate leiomyosarcoma 0 trials
-
Pulmonary artery leiomyosarcoma 0 trials
-
Pulmonary vein leiomyosarcoma 0 trials
-
Rectum leiomyosarcoma 0 trials
1 sub-type
- Anus leiomyosarcoma 0 trials
-
Superior vena cava leiomyosarcoma 0 trials
-
Vagina leiomyosarcoma 0 trials
-
Vulvar leiomyosarcoma 0 trials
-
New cocktail aims to shrink sarcomas: bevacizumab joins chemo in phase 2 trial
Disease control Not yet recruitingThis phase 2 trial tests whether adding the drug bevacizumab (Onbevzi) to standard chemotherapy (gemcitabine and docetaxel) can shrink tumors better than chemo alone in people with advanced soft tissue sarcoma. About 92 adults who have already had 1-2 prior chemotherapies will be…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental drug combo takes on rare sarcomas
Disease control Not yet recruitingThis early-phase trial tests a new drug called BOLD-100 combined with standard chemotherapy (doxorubicin) in 32 people with advanced soft tissue sarcomas that cannot be removed by surgery or have spread. The goal is to find the safest dose and see if the combination can shrink tu…
Phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC